A.P. Pharma, Inc. Share Price OTC Bulletin Board
Equities
APPA
US00202J2033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
24/06 | Heron Therapeutics, Inc.(NasdaqCM:HRTX) added to S&P Biotechnology Select Industry Index | CI |
12/06 | Connect Biopharma Names New Chief Executive, Chair | MT |
Sales 2024 * | 15Cr 1.23TCr | Sales 2025 * | 18Cr 1.48TCr | Capitalization | 53Cr 4.39TCr |
---|---|---|---|---|---|
Net income 2024 * | -1.4Cr -116.67Cr | Net income 2025 * | 10L 8.33Cr | EV / Sales 2024 * | 3.57 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.96 x |
P/E ratio 2024 * |
-38.9
x | P/E ratio 2025 * |
525
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on A.P. Pharma, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/23/16 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/21/20 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/14/13 |
1st Jan change | Capi. | |
---|---|---|
+19.41% | 4.55TCr | |
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- HRTX Stock
- APPA Stock